ALB and chronic kidney disease: Early-stage management of chronic kidney disease (CKD) by PCPs is key to reducing poor outcomes.18, 19, 20Prior studies of CDS for CKD management have been successful in reducing glomerular filtration rate (GFR) loss,21increasing rates of diagnosis,22increasing urine albumin screening,22, 23, 24, 25, 26and increasing referral to nephrologists.26However, CDS designed to improve blood pressure control has not been successful in many prior studies.21, 22, 24, 25, 27, 28, 29Our previously published pragmatic clinical trial of CDS for CKD was the first to show a statistically significant effect.30